1313714-59-8

Basic information

• Product Name: 2-Cyano-3-Methyl-4-(4-nitro-phenyl) -but-2-enoic acid ethyl ester
• Synonyms: 2-Cyano-3-Methyl-4-(4-nitro-phenyl) -but-2-enoic acid ethyl ester;Ethyl 2-cyano-3-Methyl-4-(4-nitrophenyl)but-2-enoate
• CAS NO: 1313714-59-8
• Molecular Formula: C14H14N2O4
• Molecular Weight: 274.27196
• Mol File: 1313714-59-8.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Cyano-3-Methyl-4-(4-nitro-phenyl) -but-2-enoic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Cyano-3-Methyl-4-(4-nitro-phenyl) -but-2-enoic acid ethyl ester(1313714-59-8)
• EPA Substance Registry System: 2-Cyano-3-Methyl-4-(4-nitro-phenyl) -but-2-enoic acid ethyl ester(1313714-59-8)

Safety Data

• Hazardous Substances Data: 1313714-59-8(Hazardous Substances Data)

Upstream product

• 3758-70-1 1-(4-nitrophenyl)propan-1-one 
• 105-56-6 ethyl 2-cyanoacetate 
• 5332-96-7 1-(4-nitrophenyl)propan-2-one 

Downstream Products

• 174072-89-0 2-Amino-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylic acid ethyl ester 
• 308831-93-8 2-((ethoxycarbonyl)amino)-4-methyl-5-(4-nitrophenyl)thiophene-3-carboxylic acid ethyl ester 
• 1589503-95-6 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid 
• 1589503-97-8 ethyl 2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylate 

Relevant articles and documents

Substituted pyrimidinedione compound and application thereof

The invention belongs to the technical field of medicines, and relates to a substituted pyrimidinedione compound and application thereof, and a pharmaceutical composition containing the compound, which can be used as a gonadotropin releasing hormone receptor antagonist. The invention also relates to a method for preparing the compound and the pharmaceutical composition, and application of the compound and the pharmaceutical composition in prevention or treatment of sex hormone dependent diseases including but not limited to prostate cancer, endometriosis, hysteromyoma, precocious puberty and the like.

Heterocyclyl-substituted thieno[2,3-d]pyrimidine-2,4-(1H,3H)-diketone compound and application thereof

The invention belongs to the technical field of medicines, and relates to heterocyclyl-substituted thieno[2,3-d]pyrimidine-2,4-(1H,3H)-diketone compounds and application thereof, and a pharmaceuticalcomposition containing the compounds; wherein the compounds and the pharmaceutical composition can be used as gonadotropin releasing hormone receptor antagonists. The invention also relates to a method for preparing the compound and the pharmaceutical composition, and application of the compounds and the pharmaceutical compositions in prevention or treatment of sex hormone dependent diseases, including but not limited to: prostate cancer, endometriosis, hysteromyoma, precocious puberty and the like.

Nitrogen-containing heteroaryl substituted pyrimidinedione compound and application thereof

The invention belongs to the technical field of medicines, and relates to a nitrogen-containing heteroaryl substituted pyrimidinedione compound and application thereof, and a pharmaceutical composition containing the compound, and the nitrogen-containing heteroaryl substituted pyrimidinedione compound and the pharmaceutical composition can be used as gonadotropin releasing hormone receptor antagonists. The invention also relates to a method for preparing the compound and the pharmaceutical composition, and application of the compound and the pharmaceutical composition in prevention or treatment of sex hormone dependent diseases including but not limited to prostate cancer, endometriosis, hysteromyoma, precocious puberty and the like.